Skip to main content
Erschienen in: Clinical Rheumatology 1/2004

01.02.2004 | Original Article

The significance of altered gelatinase expression in the synovium of patient with arthritic effusions

verfasst von: Ko-Hsiu Lu, Shun-Fa Yang, Shu-Chen Chu, Pei-Ni Chen, Ming-Chih Chou, Tang-Yan Hsiao, Yih-Shou Hsieh

Erschienen in: Clinical Rheumatology | Ausgabe 1/2004

Einloggen, um Zugang zu erhalten

Abstract

In this study we quantified the levels of matrix metalloproteinase-2 and 9 (MMP-2 and 9) in effusions and serial synovial cultures of patients with arthritis of the knee in order to investigate the correlations between MMP and cell counts in effusions as well as the possible roles of the synovium. In 49 patients with arthritis of the knee (series I) we examined the cell counts and the amounts of MMP-2 and 9 in 51 effusions. In 20 knee samples of series I of patients who received arthroscopy (series II), we examined the amounts of MMP-2 and 9 in effusions and serial synovial organ cultures. We also compared the gene expressions of MMP-2 and 9 and MT1-MMP in serial synovial cultures using RT-PCR. In series I, significantly more proMMP-9 appeared in effusions from the inflammatory group than in the non-inflammatory and hemorrhagic group (p <0.001). The levels of proMMP-9 correlated with the neutrophil counts in the effusions (p <0.001). In series II synovial cultures, the activities of latent and activated forms of MMP-2 and 9 in lesional areas were all higher than that in paralesional ones (p <0.05). In RT-PCR analysis, MMP-2, -9 and membrane type 1 MMP mRNA levels of lesional areas also showed increased expression. Our data suggest that the analysis of MMP-9 indicates the inflammatory condition of the joints and that additional synovectomy may be beneficial for patients with inflammatory synovitis, compared with non-inflammatory and hemorrhagic arthritis.
Literatur
1.
Zurück zum Zitat Murphy G, Knauper V, Cowell S, Hembry RM (1999) Matrix turnover in joint tissues: the role of metalloproteinases. In: Archer CW, Caterson B, Benjamin M, Ralphs JR (eds) Biology of the synovial joint. Harwood Academic Publishers, Newark, NJ, pp 177–186 Murphy G, Knauper V, Cowell S, Hembry RM (1999) Matrix turnover in joint tissues: the role of metalloproteinases. In: Archer CW, Caterson B, Benjamin M, Ralphs JR (eds) Biology of the synovial joint. Harwood Academic Publishers, Newark, NJ, pp 177–186
2.
Zurück zum Zitat Hembry RM, Dyce J, Driesang I et al. (2001) Immunolocalization of matrix metalloproteinases in partial-thickness defects in pig articular cartilage. A preliminary report. J Bone Joint Surg Am 83:826–838 Hembry RM, Dyce J, Driesang I et al. (2001) Immunolocalization of matrix metalloproteinases in partial-thickness defects in pig articular cartilage. A preliminary report. J Bone Joint Surg Am 83:826–838
3.
Zurück zum Zitat Woessner JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145–2154PubMed Woessner JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145–2154PubMed
4.
Zurück zum Zitat Matrisian LM (1992) The matrix-degrading metalloproteinases. Bioessays 14:455–463PubMed Matrisian LM (1992) The matrix-degrading metalloproteinases. Bioessays 14:455–463PubMed
5.
Zurück zum Zitat Murphy G, Docherty AJP (1992) The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 7:120–125PubMed Murphy G, Docherty AJP (1992) The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 7:120–125PubMed
6.
Zurück zum Zitat Opdenakker G, Masure S, Grillet B, Van Damme J (1991) Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. Lymphokine Cytokine Res 10:317–324PubMed Opdenakker G, Masure S, Grillet B, Van Damme J (1991) Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. Lymphokine Cytokine Res 10:317–324PubMed
7.
Zurück zum Zitat Hirose T, Reife RA, Smith GN, Stevens RM, Mainardi CL, Hasty KA (1992) Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis. J Rheumatol 19:593–599PubMed Hirose T, Reife RA, Smith GN, Stevens RM, Mainardi CL, Hasty KA (1992) Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis. J Rheumatol 19:593–599PubMed
8.
Zurück zum Zitat Omura K, Takahashi M, Omura T et al. (2002) Changes in the concentration of plasma matrix metalloproteinases (MMP) and tissue inhibitor of metalloproteinases-1 (TIMP-1) after total joint replacement in patients with arthritis. Clin Rheumatol 21:488–492PubMed Omura K, Takahashi M, Omura T et al. (2002) Changes in the concentration of plasma matrix metalloproteinases (MMP) and tissue inhibitor of metalloproteinases-1 (TIMP-1) after total joint replacement in patients with arthritis. Clin Rheumatol 21:488–492PubMed
9.
Zurück zum Zitat Koolwijk P, Miltenburg AMM, van Erck MGM et al. (1995) Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. J Rheumatol 22:385–393PubMed Koolwijk P, Miltenburg AMM, van Erck MGM et al. (1995) Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. J Rheumatol 22:385–393PubMed
10.
Zurück zum Zitat Van den Steen PE, Proost P, Grillet B et al. (2002) Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J 16:379–389CrossRefPubMed Van den Steen PE, Proost P, Grillet B et al. (2002) Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J 16:379–389CrossRefPubMed
11.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMed Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMed
12.
Zurück zum Zitat Altman R, Asch E, Bloch D et al. (1986) Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 29:1039–1049PubMed Altman R, Asch E, Bloch D et al. (1986) Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 29:1039–1049PubMed
13.
Zurück zum Zitat Lu KH, Hsiao YM, Lin ZI (1996) Arthroscopy for acute knee haemarthrosis in road traffic accident victims. Injury 27:341–343CrossRefPubMed Lu KH, Hsiao YM, Lin ZI (1996) Arthroscopy for acute knee haemarthrosis in road traffic accident victims. Injury 27:341–343CrossRefPubMed
14.
Zurück zum Zitat Kleiner DE, Stetler-Stevenson WG (1994) Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218:325–329CrossRefPubMed Kleiner DE, Stetler-Stevenson WG (1994) Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218:325–329CrossRefPubMed
15.
Zurück zum Zitat Chou FP, Chu SC, Cheng MC et al. (2002) Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors. Clin Biochem 35:383–388CrossRefPubMed Chou FP, Chu SC, Cheng MC et al. (2002) Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors. Clin Biochem 35:383–388CrossRefPubMed
16.
Zurück zum Zitat Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal Biochem 162:156–159 Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal Biochem 162:156–159
17.
Zurück zum Zitat Kuo WH, Yang SF, Chu SC, Lu SO, Chou FP, Hsieh YS (2003) Differential inductions of MMP-2 and MMP-9 in host tissue during the growth of ascitic sarcoma 180 cells in mice. Cancer Lett 189:103–112CrossRefPubMed Kuo WH, Yang SF, Chu SC, Lu SO, Chou FP, Hsieh YS (2003) Differential inductions of MMP-2 and MMP-9 in host tissue during the growth of ascitic sarcoma 180 cells in mice. Cancer Lett 189:103–112CrossRefPubMed
18.
Zurück zum Zitat Okada Y, Shinmei M, Tanaka O (1992) Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 66:680–690PubMed Okada Y, Shinmei M, Tanaka O (1992) Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 66:680–690PubMed
19.
Zurück zum Zitat Fosang AJ, Last K, Knauper V, Murphy G, Neame PJ (1996) Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 380:17–20CrossRefPubMed Fosang AJ, Last K, Knauper V, Murphy G, Neame PJ (1996) Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 380:17–20CrossRefPubMed
20.
Zurück zum Zitat Seltzer JL, Adams SA, Grant GA, Eisen AZ (1981) Purification and properities of a gelatin-specific neutral protease from human skin. J Biol Chem 256:4662–4668PubMed Seltzer JL, Adams SA, Grant GA, Eisen AZ (1981) Purification and properities of a gelatin-specific neutral protease from human skin. J Biol Chem 256:4662–4668PubMed
21.
Zurück zum Zitat Murphy G, Reynolds JJ, Bretz U, Baggiolini M (1982) Partial purification of collagenase and gelatinase from human polymorphonuclear leukocytes: analysis of their actions on soluble and insoluble collagens. Biochem J 203:209–221PubMed Murphy G, Reynolds JJ, Bretz U, Baggiolini M (1982) Partial purification of collagenase and gelatinase from human polymorphonuclear leukocytes: analysis of their actions on soluble and insoluble collagens. Biochem J 203:209–221PubMed
22.
Zurück zum Zitat Okada Y, Mordomi T, Enghild JJ et al. (1990) Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precusor and enzymatic properities. Eur J Biochem 194:721–730PubMed Okada Y, Mordomi T, Enghild JJ et al. (1990) Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precusor and enzymatic properities. Eur J Biochem 194:721–730PubMed
23.
Zurück zum Zitat Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG (1991) Human 92- and 72-kilodalton type IV collagenases and elastases. J Biol Chem 266:7870–7875PubMed Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG (1991) Human 92- and 72-kilodalton type IV collagenases and elastases. J Biol Chem 266:7870–7875PubMed
24.
Zurück zum Zitat Nguyen Q, Murphy G, Hughes CE, Mort JS, Roughley PJ (1993) Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. Biochem J 295:595–598PubMed Nguyen Q, Murphy G, Hughes CE, Mort JS, Roughley PJ (1993) Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. Biochem J 295:595–598PubMed
25.
Zurück zum Zitat Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL (1995) Immunolocalization studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovial from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 54:25–32PubMed Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL (1995) Immunolocalization studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovial from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 54:25–32PubMed
26.
Zurück zum Zitat Nagase H, Okada Y (1996) Proteinases and matrix degradation. In: Kelly WN, Harris ED Jr, Ruddy S, Sledge CB (eds) The textbook of rheumatology, 5th edn. WB Saunders, Philadelphia, pp 323–341 Nagase H, Okada Y (1996) Proteinases and matrix degradation. In: Kelly WN, Harris ED Jr, Ruddy S, Sledge CB (eds) The textbook of rheumatology, 5th edn. WB Saunders, Philadelphia, pp 323–341
27.
Zurück zum Zitat Ahrens D, koch AE, Pope RM, Stein-Picarella M, Niedbala MJ (1996) Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 39:1576–1587PubMed Ahrens D, koch AE, Pope RM, Stein-Picarella M, Niedbala MJ (1996) Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 39:1576–1587PubMed
28.
Zurück zum Zitat Grillet B, Dequeker J, Paemen L, Damme BV, Opdenakker G (1997) Gelatinase B in synovitis: immunolocalization with a monoclonical antibody. Br J Rheumatol 36:744–747CrossRefPubMed Grillet B, Dequeker J, Paemen L, Damme BV, Opdenakker G (1997) Gelatinase B in synovitis: immunolocalization with a monoclonical antibody. Br J Rheumatol 36:744–747CrossRefPubMed
29.
Zurück zum Zitat Zhang Y, McCluskey K, Fujii K, Wahl LM (1998) Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte- macrophage CSF, and IL-1 beta through prostaglandin-dependent and independent mechanism. J Immunol 161:3071–3076PubMed Zhang Y, McCluskey K, Fujii K, Wahl LM (1998) Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte- macrophage CSF, and IL-1 beta through prostaglandin-dependent and independent mechanism. J Immunol 161:3071–3076PubMed
30.
Zurück zum Zitat Pugin J, Widmer MC, Kossodo S, Liang CM, Preas HL II, Suffredini AF (1999) Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol 20:458–464PubMed Pugin J, Widmer MC, Kossodo S, Liang CM, Preas HL II, Suffredini AF (1999) Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol 20:458–464PubMed
31.
Zurück zum Zitat Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121–125PubMed Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121–125PubMed
32.
Zurück zum Zitat Fini ME, Cook JR, Mohan R, Brinckerhoff CE (1998) Regulation of matrix metalloproteinase gene expression. In: Parks WC, Mecham RP (eds) Matrix metalloproteinases. Academic Press, San Diego, pp 300–356 Fini ME, Cook JR, Mohan R, Brinckerhoff CE (1998) Regulation of matrix metalloproteinase gene expression. In: Parks WC, Mecham RP (eds) Matrix metalloproteinases. Academic Press, San Diego, pp 300–356
Metadaten
Titel
The significance of altered gelatinase expression in the synovium of patient with arthritic effusions
verfasst von
Ko-Hsiu Lu
Shun-Fa Yang
Shu-Chen Chu
Pei-Ni Chen
Ming-Chih Chou
Tang-Yan Hsiao
Yih-Shou Hsieh
Publikationsdatum
01.02.2004
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 1/2004
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-003-0774-6

Weitere Artikel der Ausgabe 1/2004

Clinical Rheumatology 1/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.